Go directly to MassDevice. Having trouble reading this email? View this newsletter in your browser here.
Not interested? Unsubscribe.
The MassDevice Weekly Roundup brings you the latest medical device news and information.
The MassDevice Checkup
Our weekly checkup takes the temperature of the public medical device companies in the three largest markets in the U.S.: Massachusetts, Minnesota and California. In addition to the indices for each state, which track the overall movement of the sector, we compare Monday morning’s opening share prices with their value when the markets close Friday afternoon and calculate the biggest gainers and losers. Read More 
News
Russian oligarch is Biopure’s new owner
A bankruptcy court approves Sergei Pugachev’s $4 million bid for the now-defunct blood substitute maker. Read More
Health Canada clears Abbott’s Xience V stent
The medical device monolith plans to immediately bring its drug-eluting stent to market north of the border. Read More
Strong 2008 drives stock gains for Thermo Fisher brass
Top executives at the Waltham, Mass.-based laboratory equipment manufacturer cash in restricted stock for a collective $470,000 profit. Read More
Study of cerebral aneurysm coiling has good news for Boston Scientific, J&J’s Cordis
The risks of re-treating brain aneurysms after endovascular coil embolization are low, according to a University of Cincinnati study. Read More
Abiomed tables Irish Impella plant
Cardiac device maker puts the brakes on the hiring drive for an Impella facility in Athlone, Ireland. Read More
HeartWare reaches clinical trial milestone
Fifty patients have been implanted with its ventricular assist system. Read More
FDA proposes new mandatory electronic filing rules
The federal watchdog wants to require manufacturers of medical devices and other products to electronically file adverse event reports. Read More
Fed court decision in Boston Scientific patent case has wide-ranging implications
A federal appeals court thwarts the Natick, Mass.-based device maker’s move to force St. Jude Medical to pony up for foreign sales of a device. Read More
Hologic touts study of fFN testing for preterm pregnancy risk
The women’s health products maker cites a British study indicating that testing pregnant women for fetal fibronectin levels can affect the way obstetricians treat their patients. Read More
Orthofix taps former Stryker exec for board
Michael Mainelli Jr. joins the board of directors of the orthopedic device maker. Read More
IntelligentMDx is ahead of schedule in developing its new Swine Flu test
The molecular diagnostics maker says it hopes to have its new influenza assay commercialized before the fast-approaching flu season. Read More
Device industry’s Q2 lobbying spend nears $8 million
Medical device industry players anted up during the second quarter, spending millions to try and influence the shape of the healthcare reform push in Washington. Read More
Studies deliver good results for Boston Scientific’s Taxus
A pair of studies bode well for the medical device leviathan’s Taxus and Taxus Express drug-eluting stents. Read More
Palomar notches its belt with another patent win
The U.S. Patent Office hands the cosmetic laser device maker another victory in its hair removal patent infringement crusade. Read More
MassDevice’s earnings roundup
A regularly updated roundup of medical device makers’ sales and earnings reports. Read More
Ronda Stryker’s selling spree continues
Total proceeds now top $52 million for the granddaughter of Stryker Corp.’s founder. Read More
Family-led fund sells one-third of Cambridge Heart stake
A father-and-son duo unloads 1.7 million shares of the Tewksbury, Mass., cardiac diagnostics firm. Read More
AdvanDx drums up $8 million
Woburn, Mass.-based molecular diagnostics maker closes Series C round. Read More
Analyst upgrades Boston Scientific
Leerink Swann analyst Rick Wise predicts good results from new CEO Ray Elliott. Read More
Orthofix lures Stryker exec away from Kalamazoo
The orthopedic device maker names a new president of its spinal implants division. Read More
Insulet taps new commercial chief
Insulin management system maker names new commercial strategy leader. Read More
Blogs
Marketing Mavens: Going beyond your intellect to engage customers
These days, you have to use everything you can to make the most of precious marketing dollars. So instead of relying on your intellect alone, why not leverage your five senses? You use sound, smell, touch, taste and sight more than you realize to dimensionalize your brand. But by being more deliberate, you can take your brand even further. Read More
Compliance Corner: Fasten your seatbelts
FDA’s new focus on more stringent enforcement could mean a roller coaster ride for medical device manufacturers. Read More
Career Sampler: Open jobs in the medical device industry
An updated sampling of some of the hundreds of open positions at medical device makers around the country. Read More
Weekly Wireless Roundup: The Bluetooth stethoscope
3M unveils a new Bluetooth-enable stethoscope; reports on the efficacy of mHealth initiatives and remote patient monitoring; and new FTC rules for electronic health records. Read More
MedGadget’s MedTech Monday: Are IV bags the next fashion statement?
Check out designer Olivier Trillon’s designer-brand IV drip bags; FDA green-lights a French company’s bladder stone disintegrator; multimedia in the birthing suite; and using jet fighter technology in coronary bypass. Read More
Upcoming Events
September 10-11th, Boston — Inaugural Medical Device Connectivity Conference
September 16th, Waltham, Mass. — Medical Development Group networking event: “Supernetworking: Start-up Funding in Hard Times”
NEW – October 2nd, Boston: MassMEDIC’s Annual Investors Conference
“New England is a hotbed of cutting-edge research in the medtech industry. MassMEDIC is proud to offer an opportunity for regional promising early stage companies to showcase their technologies before an audience of potential investors and strategic partners. The Investors Conference has been a seminal event for medtech start-ups, more than 250 companies have participated in the Conference since 1999 — many making their debut before investors.
“While the primary focus of the Investors Conference is on finance and investment, the annual program has also become an outstanding networking event, drawing more than 450 attendees representing every facet of medtech’s finance, manufacturing, development and service supply sectors.”
For more information visit MassMEDIC’s website.
If you would like to subscribe to this newsletter, please visit our member registration page.
© 2009 Massachusetts Medical Devices Journal LLC and its licensors. All rights reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of MMDJ.
